These two things may help reduce high blood pressure in obesity
In a new statement from American Heart Association, researchers suggest that weight-loss medications and surgery show promise for reducing high blood pressure (also called...
Does COVID-19 virus become less deadly?
Variants of the coronavirus have come to represent the ultimate danger: A curveball in our plans to bring an end to the pandemic that...
This drug can be a low-cost heart failure treatment
In a study from the University of Shizuoka, researchers found sarpogrelate, an antiplatelet medication, has potential as a new heart failure therapy and may...
Scientists find how to prevent frontotemporal dementia
Frontotemporal dementias are a group of fatal and debilitating brain disorders for which there are no cures.
This form of the disease is caused by...
Quick recognition, treatment help Maine stroke survivor recover in hours
Before her pre-dawn runs, Sarah Belliveau likes fueling herself with a cup of coffee.
The morning of June 15, 2017, she couldn’t. She forgot how.
“I...
Common drugs for inflammation, depression, alcoholism may treat COVID-19
Several recent studies have found that common drugs for depression, alcoholism, and inflammation may help treat COVID-19.
In a study published in JAMA Network Open, UCSF...
COVID booster shot can cut your death risk by 90%
In two new studies from Israeli, researchers found booster doses of Pfizer's coronavirus vaccine set recipients up to effectively withstand the ravages of both...
Blood pressure rising at night may double death risk in people with diabetes
In a study from the University of Pisa, researchers found people with type 1 or type 2 diabetes whose blood pressure increased at night...
Are some foods super bitter to you? You may have lower COVID-19 risk
In a recent study from Baton Rouge General Medical Center, researchers found people who can't stand broccoli, celery or kale may be supertasters, and...
Alzheimer’s drug aducanumab: Unjust profits and false hopes
In a report from Michigan State University, researchers suggest that the U.S. Food and Drug Administration's decision to approve aducanumab for the treatment of...